Comparative study of the effect of bilastine and cetirizine on cognitive functions at ground level and at an altitude of 4,000 m simulated in hypobaric chamber: a randomized, double-blind, placebo-controlled, cross-over study
- PMID: 30032673
- DOI: 10.1080/14740338.2018.1502268
Comparative study of the effect of bilastine and cetirizine on cognitive functions at ground level and at an altitude of 4,000 m simulated in hypobaric chamber: a randomized, double-blind, placebo-controlled, cross-over study
Abstract
Introduction: Antihistamines are easily accessible and cover the vast majority of the medical therapy of allergic rhinitis. However, their systemic administration may more frequently associate with their well-known side-effect, sedation, which is a serious problem in persons in safety-critical jobs such as aviation. We have a poor understanding whether a non-sedative antihistamine has an impact on vigilance when hypobaric hypoxia occurs during flight.
Methods: In this randomized, placebo-controlled, double-blind, cross-over study the effect of 20 mg bilastine was compared to 10 mg cetirizine and to placebo (20 mg pyridoxine) in 33 individuals at ground level and at 4,000 m altitude simulated in hypobaric chamber. Levels of vigilance, ultrashort memory, combined distributive attention, monotony tolerance and peripheral blood oxygen saturation (SpO2) were assessed.
Results: Bilastine did not impair the tested abilities in comparison with the control groups either at ground level or hypobaric hypoxia. Administration of cetirizine increased the number of errors at ground level. At the simulated altitude, already impaired results were additionally demonstrated with regards to the distributive attention test.
Conclusions: From the two examined antihistamines, bilastine should be the preferred medication for by individuals who require constant attention and are exposed to hypobaric hypoxia.
Keywords: Antihistamine; attention; aviation; cognitive capability; hypobaric hypoxia; sedation; vigilance.
Similar articles
-
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.Clin Exp Allergy. 2009 Sep;39(9):1338-47. doi: 10.1111/j.1365-2222.2009.03257.x. Epub 2009 May 4. Clin Exp Allergy. 2009. PMID: 19438584 Clinical Trial.
-
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.Curr Med Res Opin. 2012 Jan;28(1):121-30. doi: 10.1185/03007995.2011.640667. Epub 2011 Nov 30. Curr Med Res Opin. 2012. PMID: 22077106 Clinical Trial.
-
Cognitive Performance Effects of Bilastine 20 mg During 6 Hours at 8000 ft Cabin Altitude.Aerosp Med Hum Perform. 2016 Jul;87(7):622-7. doi: 10.3357/AMHP.4522.2016. Aerosp Med Hum Perform. 2016. PMID: 27503042 Clinical Trial.
-
Safety profile of bilastine: 2nd generation H1-antihistamines.Eur Rev Med Pharmacol Sci. 2012 Dec;16(14):1999-2005. Eur Rev Med Pharmacol Sci. 2012. PMID: 23242729 Review.
-
Bilastine: a new antihistamine with an optimal benefit-to-risk ratio for safety during driving.Expert Opin Drug Saf. 2016 Jan;15(1):89-98. doi: 10.1517/14740338.2016.1112786. Epub 2015 Nov 16. Expert Opin Drug Saf. 2016. PMID: 26571227 Review.
Cited by
-
Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study.Perspect Clin Res. 2023 Oct-Dec;14(4):180-186. doi: 10.4103/picr.picr_28_23. Epub 2023 Aug 8. Perspect Clin Res. 2023. PMID: 38025284 Free PMC article.
-
Sensitivity of cognitive function tests to acute hypoxia in healthy subjects: a systematic literature review.Front Physiol. 2023 Oct 11;14:1244279. doi: 10.3389/fphys.2023.1244279. eCollection 2023. Front Physiol. 2023. PMID: 37885803 Free PMC article.
-
Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis.Front Pharmacol. 2022 Jan 10;12:731201. doi: 10.3389/fphar.2021.731201. eCollection 2021. Front Pharmacol. 2022. PMID: 35082662 Free PMC article. Review.
-
Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions.Drugs Context. 2021 Aug 10;10:2021-5-1. doi: 10.7573/dic.2021-5-1. eCollection 2021. Drugs Context. 2021. PMID: 34457015 Free PMC article. Review.
-
The safety and tolerability profile of bilastine for chronic urticaria in children.Clin Transl Allergy. 2019 Oct 23;9:55. doi: 10.1186/s13601-019-0294-3. eCollection 2019. Clin Transl Allergy. 2019. PMID: 31660121 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
